Cancer

UV ray exposure contributes to millions of skin cancer cases each year. Learn how to protect your skin to reduce your sunburn and skin cancer risks.

Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

Learn about the health benefits of a traditional Asian diet at this free, online education event presented by Providence Cancer Institute and the Asian Health & Service Center.

Although skin protection is important year-round, the summer is a good time to review helpful tips and tricks to help keep your skin safe while you enjoy the outdoors.

Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.

Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.

Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.

A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.

Ovarian Cancer Alliance and Providence Cancer Institute to host free education event on June 29 for ovarian cancer patients and their caregivers.

May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.

Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

Grays Harbor man an example of the benefits of the Providence Medication Assistance Program.

Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.

Providence nurses Cynthia Clements and Chris Cothran share what keeps them motivated in the ever-changing nursing environment.

Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

Register for a free virtual education event on April 19 for Mantle Cell Lymphoma patients, presented by the Leukemia & Lymphoma Society (LLS) and Providence Cancer Institute of Oregon.

Urologist James Kuan, MD explains the ABCs of prostate cancer, including screening, early detection and potential side effects of treatment.

A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.